Antithrombotic Therapy in Patients With Acute Coronary Syndromes

  title={Antithrombotic Therapy in Patients With Acute Coronary Syndromes},
  author={Glenn N. Levine and Muhammad Ali and Andrew I. Schafer},
T he potential armamentarium of agents used in the treatment of acute coronary syndromes continues to expand, including such well-tested agents as aspirin, unfractionated heparin, and earlier-generation fibrinolytic agents, and newer agents such as lowmolecular-weight heparins, direct thrombin inhibitors, thienopyridines, platelet glycoprotein IIb/IIIa receptor inhibitors, and bolus-administration fibrinolytic agents. Older and newer antithrombotic agents have undergone and continue to undergo… CONTINUE READING